Moderna COVID-19 Vaccine Deemed Safe by FDA Panel After Pfizer Authorization

A detailed analysis of the COVID-19 vaccine from Moderna was released by the Food and Drug Administration (FDA) Tuesday morning. The analysis affirmed that the vaccine is effective and safe, with a 94% efficacy rate. The same committee that advised the FDA on the approval of the Pfizer vaccine met again on Thursday to discuss the Moderna vaccine. The panel voted 20-0 in support of endorsing the vaccine and recommended the agency grant emergency authorization. It is expected that the FDA will authorize emergency use authorization as soon as today. Between both the Moderna and Pfizer vaccines, officials expect to administer the first dose to 20 million people by the end of 2020.

Click here to read more on this story.